glp-1 weight loss marketing Crafting product claims in the weight-loss drug era How Brands Can Market to

The findings can provide some reassurance for pregnant women with unintentional first trimester exposure to GLP-1 RAs, however, further research is warranted to better understand the safety of these medications during pregnancy

Semaglutide GLP-1 injections come as a fresh approach to medical weight loss in that it has been shown to provide much more significant results than other options that are available on the market when used alongside a healthy diet and exercise regimen

Starting at a lower dose and increasing gradually can help reduce GI side effects, including diarrhea

GLP-1 medications are not just weight loss drugs. These powerful medications, formally known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), offer many health benefits that go far beyond shedding pounds

For semaglutide, microdosing might mean starting at 0.1 mg weekly instead of 0.25 mg, or staying at 0.25 mg for 8 weeks instead of 4 before escalating